Tenaya Therapeutics Inc’s Market Journey: Closing Strong at 2.98, Up 2.05

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The closing price of Tenaya Therapeutics Inc (NASDAQ: TNYA) was $2.98 for the day, up 2.05% from the previous closing price of $2.92. In other words, the price has increased by $2.05 from its previous closing price. On the day, 1.11 million shares were traded. TNYA stock price reached its highest trading level at $3.2237 during the session, while it also had its lowest trading level at $2.88.


Our analysis of TNYA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.72 and its Current Ratio is at 6.72. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.05.

On November 30, 2023, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $7.

On June 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.H.C. Wainwright initiated its Buy rating on June 15, 2022, with a $25 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 05 ’24 when Hoey Timothy sold 3,300 shares for $7.00 per share. The transaction valued at 23,101 led to the insider holds 245,346 shares of the business.

Hoey Timothy sold 6,569 shares of TNYA for $35,046 on Feb 20 ’24. The Chief Scientific Officer now owns 236,146 shares after completing the transaction at $5.34 per share. On Feb 16 ’24, another insider, Tingley Whittemore, who serves as the Chief Medical Officer of the company, sold 6,500 shares for $5.86 each. As a result, the insider received 38,090 and left with 73,534 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNYA now has a Market Capitalization of 233982160 and an Enterprise Value of 123099248.

Stock Price History:

The Beta on a monthly basis for TNYA is 2.42, which has changed by -0.4552102 over the last 52 weeks, in comparison to a change of 0.2553556 over the same period for the S&P500. Over the past 52 weeks, TNYA has reached a high of $7.01, while it has fallen to a 52-week low of $1.66. The 50-Day Moving Average of the stock is -23.66%, while the 200-Day Moving Average is calculated to be -17.75%.

Shares Statistics:

TNYA traded an average of 347.71K shares per day over the past three months and 731890 shares per day over the past ten days. A total of 68.33M shares are outstanding, with a floating share count of 65.25M. Insiders hold about 16.90% of the company’s shares, while institutions hold 55.82% stake in the company. Shares short for TNYA as of 1718323200 were 3384721 with a Short Ratio of 9.73, compared to 1715731200 on 3349411. Therefore, it implies a Short% of Shares Outstanding of 3384721 and a Short% of Float of 6.2.

Most Popular